clinical
Articles tagged with “clinical”
Telemedicine Monitoring Protocols for At-Home Ketamine Therapy
Evidence-based guidance on remote monitoring protocols for at-home ketamine administration, covering vital sign monitoring, telehealth check-ins, safety frameworks, and technology requirements.
Measuring Ketamine Treatment Outcomes: Validated Assessment Tools
Review of validated assessment tools for measuring ketamine treatment outcomes, covering depression rating scales, suicidality measures, functional assessments, and biomarkers.
Telehealth Ketamine Marketing Compliance: Regulatory and Ethical Guidelines
Regulatory guide for marketing at-home ketamine therapy and esketamine services, covering FDA rules, DEA requirements, and state telemedicine laws.
How to Start a Ketamine Therapy Practice: A Clinician's Guide
A comprehensive guide for clinicians on launching a ketamine therapy practice, covering DEA licensing, state regulations, clinical protocols, compounding pharmacy partnerships, liability considerations, and insurance frameworks.
How to Prepare for Your First Ketamine Therapy Session
A comprehensive patient-oriented guide to preparing for an initial ketamine treatment session, covering what to expect, pre-treatment medical requirements, medication considerations, practical logistics, and strategies for optimizing treatment outcomes.
Ketamine Therapy in Rural Communities: Overcoming Access Barriers
An analysis of the unique challenges and innovative solutions for delivering low-dose ketamine therapy to patients in rural and underserved communities, including telehealth models, mobile clinics, and provider training strategies.
Patient Selection Criteria for Low-Dose Ketamine Therapy
Evidence-based patient selection criteria for low-dose ketamine therapy, covering indications, contraindications, risk-benefit assessment, and clinical decision-making frameworks.
How Much Does Ketamine Therapy Cost?
A single ketamine IV infusion typically costs between $400 and $800, with a full initial course of 6 infusions ranging from $2,400 to $4,800.
Low-Dose Ketamine in Emergency Psychiatry: Acute Management Protocols
Review of low-dose ketamine in emergency psychiatry settings, covering acute suicidal ideation management, agitation protocols, ED implementation, and rapid assessment frameworks.
Clinically Significant Drug Interactions with Low-Dose Ketamine
A comprehensive review of clinically significant drug interactions with therapeutic ketamine, covering CNS depressants, serotonergic agents, CYP enzyme inhibitors, and cardiovascular medications.
Informed Consent for Ketamine Treatment: Essential Elements
Guide to informed consent for ketamine treatment, covering essential disclosure elements, off-label considerations, risk communication, and documentation best practices.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
Five anonymized clinical case studies illustrating treatment outcomes with low-dose ketamine across treatment-resistant depression, PTSD, chronic pain, and bipolar depression, with detailed dosing, timelines, and clinical lessons.
Geriatric Considerations in Low-Dose Ketamine Therapy
Clinical guidance on low-dose ketamine use in elderly patients, addressing age-related pharmacokinetic changes, cardiovascular risk stratification, cognitive monitoring, and dose modifications.
Does Insurance Cover Ketamine Therapy?
Most insurance plans do not cover IV ketamine infusions for depression, though FDA-approved intranasal esketamine (Spravato) has broader insurance coverage.
Cost-Effectiveness of Ketamine Therapy: Health Economic Evidence
Health economic analysis of ketamine therapy cost-effectiveness, examining direct treatment costs, comparative value versus alternatives, QALY gains, and payer perspectives.
Ready to learn more?
Explore our comprehensive guides and tools to help you navigate your ketamine therapy journey.